期刊文献+

受体酪氨酸蛋白激酶的研究 被引量:10

Research Progress of Receptor Tyrosine Protein Kinase
下载PDF
导出
摘要 酪氨酸蛋白激酶是细胞信号转导的主要信号酶之一,对细胞的生长、发育与功能调控起着重要的作用。受体型酪氨酸蛋白激酶是细胞内段具有酪氨酸激酶活性跨膜结构的酶蛋白受体,其胞外区与生长因子配体结合,然后激活胞内段的酶活性区启动信号转导,参与细胞的生长、增殖、转化及胚胎发育和肿瘤形成。主要介绍受体型酪氨酸蛋白激酶的结构、分类及其信号转导途径。 Tyrosine protein kinase is one of the key kinases in cell signal transduction,which plays an important role in cell growth, development and functional regulation, Receptor tyrosine protein kinase is a transmembrane kinase protein receptor with tyrosine protein kinase activity on intracellular part, it can actuate the signal transduction by activating the active zone of its intracellular part resulting from the combination of its extroeellular part with its growth factor ligand and then takes part in the cell growth, cell proliferation, cell transdifferenfiation, embryonic development and tumor genesis. This article mainly reviews receptor tyrosine protein kinase about its structure, classification and its signal transduction pathway,
出处 《医学综述》 2008年第12期1780-1781,共2页 Medical Recapitulate
关键词 受体酪氨酸蛋白激酶 信号转导 丝裂原活化蛋白激酶 Receptor tyrosine protein kinase Signal transduction Mitogen activited protein kinase
  • 相关文献

参考文献20

  • 1Harvey L, Arnold B, Lawrence SZ, et al. Molecular cell biology [ M ]. Fourth Edition. New York: W. H. Freeman and Company, 2000 : 128-152.
  • 2Li E, Hristova K. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies [ J ]. Biochemistry,2006,45 (20) :6241-6251.
  • 3郭晓宁,林莉萍,章雄文,丁健.表皮生长因子受体酪氨酸激酶家族与肿瘤治疗[J].中国新药杂志,2005,14(10):1136-1140. 被引量:8
  • 4Lavioh L, Natalicchio A, Giorgino F. The IGF-I signaling pathway [ J]. Curr Pharm Des,2007,13 (7) :663-669.
  • 5Lewis NL. The platelet-derived growth factor receptor as a therapeutic target[J]. Curr Oncol Rep,2007,9(2) :89-95.
  • 6Bourette RP, Rohrsehneider LR. Early events in M-CSF receptor signaling[ J]. Growth Factors ,2000,17 (3) : 155-166.
  • 7Tanaka H. Fibroblast growth factor receptor and achondroplasia [ J ]. Clin Calcium,2006,16 ( 11 ) : 1888-1893.
  • 8Reichardt LF. Neurotrophin-regulated signalling pathways [ J ]. Philos Trans R Soc Lond B Biol Sci,2006,361 (1473) :1545-1564.
  • 9Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors [ J ]. Mol Divers, 2006, 10 ( 4 ) : 515-527.
  • 10Sattler M, Salgia R. c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy[ J ]. Curr Oncol Rep ,2007,9 (2) : 102-108.

二级参考文献55

  • 1程飚,付小兵,盛志勇,孙同柱,孙晓庆,李建福.瘢痕形成的分子机制初探:瘢痕组织与成人正常皮肤中EGFR与FGFR2表达差异的对比[J].中国组织工程研究与临床康复,2001,10(20):66-67. 被引量:1
  • 2程飙,付小兵,盛志勇,孙同柱,孙晓庆,李建福.创伤修复中细胞信号传递对瘢痕形成的影响:SH2功能领域蛋白酪氨酸磷酸酶的表达及意义[J].中国组织工程研究与临床康复,2001,10(22):50-51. 被引量:4
  • 3[1]Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy[ J]. Oncogene, 2000,19(56) :6550 - 6565.
  • 4[2]Yarden Y,Sliwkowski MX. Untangling the ErbB signaling network[ J ]. Nat Rev Mol Cell Biol,2001,2(2): 127 - 137.
  • 5[3]Normanno N, Maiello MR, de Luca A. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) :simple drugs with a complex mechanism of action? [J]. J Cell Physiol, 2003, 194( 1 ):13 - 19.
  • 6[4]Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression[J]. Exp Cell Res ,2003,284(1) :99 - 110.
  • 7[5]Graus Porta D, Beerli RR, Daly JM, et al. ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling[J]. EMBO J, 1997,16(7): 1647 - 1655.
  • 8[6]Zvibel J, Brill S, Halpern Z, et al. Soluble and matrix-associated heparan sulfate proteoglycans increase expression of ErbB-2 and ErbB-3 in colon cancer cell lines[J]. Int J Cancer, 2001,91 (3) :316 -321.
  • 9[7]Crovello CS,Lai C, Cantley LC, et al. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2 [ J ]. J Biol Chem, 1998,273 (41 ): 26954 - 26961.
  • 10[8]Gamett DC, Pearson G, Cerione RA, et al. Secondary dimerization between members of the epidermal growth factor receptor family[J]. J Biol Chem, 1997,272(18): 12052 - 12056.

共引文献278

同被引文献152

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部